ResMed Inc. (ASX: RMD)
Australia
· Delayed Price · Currency is AUD
37.08
+0.55 (1.51%)
Nov 21, 2024, 4:10 PM AEST
ResMed Revenue
ResMed had revenue of $1.22B USD in the quarter ending September 30, 2024, with 11.08% growth. This brings the company's revenue in the last twelve months to $4.81B, up 9.88% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.
Revenue (ttm)
$4.81B
Revenue Growth
+9.88%
P/S Ratio
n/a
Revenue / Employee
$481.71K
Employees
9,980
Market Cap
54.63B AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
Pro Medicus Limited | 161.50M |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Ramsay Health Care Limited | 16.66B |
Telix Pharmaceuticals Limited | 645.68M |
Clarity Pharmaceuticals Ltd | 11.51M |
ResMed News
- 3 days ago - ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year - Investor's Business Daily
- 7 days ago - Insider Sale: Director Witte De Sells Shares of ResMed Inc (RMD) - GuruFocus
- 9 days ago - Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030 - Benzinga
- 12 days ago - Insider Sale: Director Peter Farrell Sells Shares of ResMed Inc (RMD) - GuruFocus
- 15 days ago - ResMed Announces Participation in the UBS Global Healthcare Conference - GlobeNewsWire
- 17 days ago - My Top 15 High-Growth Dividend Stocks For November 2024 - Seeking Alpha
- 24 days ago - P/E Ratio Insights for ResMed - Benzinga
- 27 days ago - Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst - Benzinga